Partner Content Partner Content 1 week to SMi’s Superbugs & Superdrugs - REMOTE ACCESS ONLY 1 week to Superbugs & Superdrugs - REMOTE ACCESS ONLY
Partner Content Partner Content Interview with Martin Everett speaker at SMi’s Superbugs & S... Interview with Martin Everett speaker at Superbugs
Views & Analysis Who will pay the price for inaction on superbugs? While the UK government has been applauded for its efforts in raising awareness about antimicrobial resistance, its efforts to convince pharma to invest in new antibiotics have so far been
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
